Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer
- PMID: 29778522
- PMCID: PMC5986968
- DOI: 10.1016/j.ymthe.2018.05.008
Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer
Comment on
-
miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer.Mol Ther. 2018 Mar 7;26(3):744-754. doi: 10.1016/j.ymthe.2017.12.023. Epub 2018 Jan 4. Mol Ther. 2018. PMID: 29475734 Free PMC article.
References
-
- Drebber U., Lay M., Wedemeyer I., Vallböhmer D., Bollschweiler E., Brabender J., Mönig S.P., Hölscher A.H., Dienes H.P., Odenthal M. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int. J. Oncol. 2011;39:409–415. - PubMed
-
- Yang P., Yang Y., An W., Xu J., Zhang G., Jie J., Zhang Q. The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway. J. Gastroenterol. Hepatol. 2017;32:837–845. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
